Savita Rangarajan

Publications

90 publications

Page 6 of 9

Long-term safety and efficacy of factor IX gene therapy in hemophilia B

Amit C. Nathwani, Ulreke M. Reiss, Edward G.d. Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny Mcintosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj, Anne Riddell, Jun Pie, Savita Rangarajan, David Bevan, Michael Recht, Yu-min Shen, Kathleen G. Halka, Etiena Basner-tschakarjan, Federico Mingozzi, Katherine A. High, James Allay, Mark A. Kay, Catherine Y.c. Ng, Junfang Zhou, Maria Cancio, Christopher L. Morton, John T. Gray, Deokumar Srivastava, Arthur W. Nienhuis & Andrew M. Davidoff, 2014, New England Journal of Medicine, 371(21), 1994-2004

DOI: 10.1056/NEJMoa1407309

Type: article

Adult haemophilia A patients with inhibitors

Savita Rangarajan, V. Jiménez-Yuste & E. Santagostino, 2014, Haemophilia, 20(6), e414-e417

DOI: 10.1111/hae.12521

Type: letterEditorial

[Poster Presentation] A UKHCDO National Survey of the management of acquired haemophilia A

P. Batty, P.W. Collins, E. Chalmers, C.R. Hay, R. Liesner, B. Palmer, S. Rangarajan, K. Talks, M. Williams & D.P. Hart, 2014, Haemophilia, 20(s2), 31

Type: conference

The clinical implications of ADAMTS13 function

Savita Rangarajan, Craig Kessler & Louis Aledort, 2013, Thrombosis Research, 132(4), 403-407

DOI: 10.1016/j.thromres.2013.07.027

Type: review

Diagnosis and management of acquired coagulation inhibitors

Peter W Collins, Elizabeth Chalmers, Daniel Hart, Ian Jennings, Ri Liesner, Savita Rangarajan, Kate Talks, Michael Williams & Charles R M Hay, 2013, British Journal of Haematology, 162(6), 758-773

DOI: 10.1111/bjh.12463

Type: article

Consensus recommendations for the use of FEIBA^® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery

S. Rangarajan, S. Austin, N. J. Goddard, C. Négrier, E. C. Rodriguez-Merchan, D. Stephensen & T. T. Yee, 2013, Haemophilia, 19(2), 294-303

DOI: 10.1111/hae.12028

Type: article

Will gene therapy trump factor treatment in hemophilia?

Savita Rangarajan & Louis Aledort, 2013, Expert Review of Hematology, 6(1), 43-48

DOI: 10.1586/ehm.12.70

Type: review

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization

Peter W Collins, Elizabeth Chalmers, Daniel P Hart, Ri Liesner, Savita Rangarajan, Kate Talks, Mike Williams & Charles R Hay, 2013, British Journal of Haematology, 160(2), 153-170

DOI: 10.1111/bjh.12091

Type: article

Hum1an-cl rhFVIII effectively and safely prevents bleeding episodes in previously treated adult patients with severe haemophilia A

S. Knaub, T. Lissitchkov, K. Hampton, S. Rangarajan, J. Bichler & J. Oldenburg, 2013, Haemophilia, 19(3), 468

Type: conference

The incidence of factor VIII inhibitors in severe haemophilia a following a major product switch in the UK: a prospective controlled study in 1214 previously treated patients

C. R. M. Hay, P. Collins, B. Palmer, R. Liesner, E. Chalmers, D. Hart, S. Rangarajan, K. Talks & M. Williams, 2013, Journal of Thrombosis and Haemostasis, 12(11), 9

Type: conference

Professor Savita Rangarajan

Connect with Savita

Publications